AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(5), 2001, pp. 588-592
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayxay, M
Right arrow Articles by White, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayxay, M
Right arrow Articles by White, N.
Related Collections
Right arrow Travel Medicine
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 5, 588-592
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria

M Mayxay, S Pukritrayakamee, K Chotivanich, M Imwong, S Looareesuwan, and NJ White

In Thailand, approximately 8% of patients treated for vivax malaria are found subsequently to have coinfection with Plasmodium falciparum. A P. falciparum histidine rich protein 2 (PfHRP-2) dipstick test was evaluated as a predictor of mixed infections with subpatent P. falciparum in a prospective study of 238 patients admitted to the hospital with acute vivax malaria. Of these, 23 (10%) had subsequent development of falciparum malaria without reexposure. Patients with cryptic P. falciparum infection had a significantly lower mean (standard deviation) hematocrit than those with P. vivax alone: 29.6 (7.6%) versus 37.2 (6.4%) (P < 0.0001). Using microscopic appearance of P. falciparum after the start of treatment as the reference standard, the PfHRP-2 test was 74% sensitive and 99% specific in predicting mixed infections with subpatent P. falciparum parasitemia at presentation. The PfHRP-2 dipstick test may be a useful adjunct to microscopy in areas where mixed infections are common.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
K. Rungsihirunrat, C. H. Sibley, M. Mungthin, and K. Na-Bangchang
Geographical Distribution of Amino Acid Mutations in Plasmodium vivax DHFR and DHPS from Malaria Endemic Areas of Thailand
Am J Trop Med Hyg, March 1, 2008; 78(3): 462 - 467.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. Marfurt, I. Mueller, A. Sie, P. Maku, M. Goroti, J. C. Reeder, H.-P. Beck, and B. Genton
Low Efficacy of Amodiaquine or Chloroquine Plus Sulfadoxine-Pyrimethamine against Plasmodium falciparum and P. vivax Malaria in Papua New Guinea
Am J Trop Med Hyg, November 1, 2007; 77(5): 947 - 954.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
K. RUNGSIHIRUNRAT, K. NA-BANGCHANG, V. N. HAWKINS, M. MUNGTHIN, and C. H. SIBLEY
SENSITIVITY TO ANTIFOLATES AND GENETIC ANALYSIS OF PLASMODIUM VIVAX ISOLATES FROM THAILAND
Am J Trop Med Hyg, June 1, 2007; 76(6): 1057 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
H. NOEDL, K. YINGYUEN, A. LAOBOONCHAI, M. FUKUDA, J. SIRICHAISINTHOP, and R. S. MILLER
SENSITIVITY AND SPECIFICITY OF AN ANTIGEN DETECTION ELISA FOR MALARIA DIAGNOSIS
Am J Trop Med Hyg, December 1, 2006; 75(6): 1205 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley
Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
U. SILACHAMROON, S. KRUDSOOD, S. TREEPRASERTSUK, P. WILAIRATANA, K. CHALEARMRULT, H. Y. MINT, P. MANEEKAN, N. J. WHITE, V. R. GOURDEUK, G. M. BRITTENHAM, et al.
CLINICAL TRIAL OF ORAL ARTESUNATE WITH OR WITHOUT HIGH-DOSE PRIMAQUINE FOR THE TREATMENT OF VIVAX MALARIA IN THAILAND
Am J Trop Med Hyg, July 1, 2003; 69(1): 14 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. D. Hastings and C. H. Sibley
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax
PNAS, October 1, 2002; 99(20): 13137 - 13141.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.